Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meriem Tazir

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Archives of Neurology|September 13, 2006
Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutationsLianna Ishihara, Liling Warren, Rachel Gibson, et al.
Clinical Genetics|February 25, 2025
NEUROMYODredger: Whole Exome Sequencing for the Diagnosis of Neurodevelopmental and Neuromuscular Disorders in Seven CountriesEdoardo Malfatti, Alexandru Caramizaru, Hane Lee, et al.
American Journal of Human Genetics|March 6, 2008
ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiencyClotilde Lagier-Tourenne, Meriem Tazir, Luis Carlos López, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 23, 2018
Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS studyJaime Luna, Mouhamadou Diagana, Leila Ait Aissa, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 30, 2021
Clinical management and disease-modifying treatment for amyotrophic lateral sclerosis in African hospital centers: the TROPALS studyJaime Luna, Jeremy Jost, Mouhamadou Diagana, et al.
Journal of Neurology|May 5, 2016
Validation of a clinical practice-based algorithm for the diagnosis of autosomal recessive cerebellar ataxias based on NGS identified casesMartial Mallaret, Mathilde Renaud, Claire Redin, et al.
Nature Genetics|February 27, 2007
Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosumGiovanni Stevanin, Filippo M Santorelli, Hamid Azzedine, et al.
The Lancet. Neurology|October 4, 2016
DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association studyJoanne Trinh, Emil K Gustavsson, Carles Vilariño-Güell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2020
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease PenetranceMarta San Luciano, Caroline M Tanner, Cheryl Meng, et al.
Human Molecular Genetics|March 4, 2010
Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humansSuzanne Lesage, Etienne Patin, Christel Condroyer, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Archives of Neurology|September 13, 2006
Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutationsLianna Ishihara, Liling Warren, Rachel Gibson, et al.
Clinical Genetics|February 25, 2025
NEUROMYODredger: Whole Exome Sequencing for the Diagnosis of Neurodevelopmental and Neuromuscular Disorders in Seven CountriesEdoardo Malfatti, Alexandru Caramizaru, Hane Lee, et al.
American Journal of Human Genetics|March 6, 2008
ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiencyClotilde Lagier-Tourenne, Meriem Tazir, Luis Carlos López, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 23, 2018
Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS studyJaime Luna, Mouhamadou Diagana, Leila Ait Aissa, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 30, 2021
Clinical management and disease-modifying treatment for amyotrophic lateral sclerosis in African hospital centers: the TROPALS studyJaime Luna, Jeremy Jost, Mouhamadou Diagana, et al.
Journal of Neurology|May 5, 2016
Validation of a clinical practice-based algorithm for the diagnosis of autosomal recessive cerebellar ataxias based on NGS identified casesMartial Mallaret, Mathilde Renaud, Claire Redin, et al.
Nature Genetics|February 27, 2007
Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosumGiovanni Stevanin, Filippo M Santorelli, Hamid Azzedine, et al.
The Lancet. Neurology|October 4, 2016
DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association studyJoanne Trinh, Emil K Gustavsson, Carles Vilariño-Güell, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 15, 2020
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease PenetranceMarta San Luciano, Caroline M Tanner, Cheryl Meng, et al.
Human Molecular Genetics|March 4, 2010
Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humansSuzanne Lesage, Etienne Patin, Christel Condroyer, et al.
Pageof 6